CNS Drugs

Role of Melatonin in the Pathophysiology of Migraine: Implications for Treatment
pp. 343-350(8)
Authors: Vogler, Barbara; Rapoport, Alan M.; Tepper, Stewart J.; Sheftell, Fred; Bigal, Marcelo E.

Inhibition of γ-Secretase as a Therapeutic Intervention for Alzheimer's Disease: Prospects, Limitations and Strategies
pp. 351-372(22)
Authors: Evin, Geneviève; Marijke Fleur Sernee,; Masters, Colin L.

Management of Epilepsy in Women of Childbearing Age: Practical Recommendations
pp. 373-387(15)
Author: Tettenborn, Barbara

Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia
pp. 389-409(21)
Authors: Horacek, Jiri; Bubenikova-Valesova, Vera; Kopecek, Milan; Palenicek, Tomas; Dockery, Colleen; Mohr, Pavel; Höschl, Cyril

Cardiovascular Effects and Risk of Syncope Related to Donepezil in Patients with Alzheimer's Disease
pp. 411-417(7)
Authors: Bordier, Philippe; Garrigue, Stephane; Lanusse, Stephane; Margaine, Julien; Robert, Frederic; Gencel, Laurent; Lafitte, Alexia

Zolpidem Extended-Release
pp. 419-426(8)
Authors: Moen, Marit D.; Plosker, Greg L.

Zolpidem Extended-Release: A Viewpoint by Ian Hindmarch
pp. 427-427(1)
Author: Hindmarch, Ian

Zolpidem Extended-Release: A Viewpoint by David N. Neubauer
pp. 428-428(1)
Author: Neubauer, David N.

Spotlight on Quetiapine in Acute Mania and Depression Associated with Bipolar Disorder
pp. 429-431(3)
Authors: Dando, Toni M.; Keating, Gillian M.